LUMINARY THERAPEUTICS

luminary-therapeutics-logo

Luminary Therapeutic is a cancer research center that develops pre-clinical stage cell therapy for cancer and autoimmune diseases. It creates an engine that completes novel and early therapeutic discovery through Phase I clinical trial completion, enabling doctors to eliminate viral-based cell therapy issues. The company was founded in 2019 and is based in Minneapolis, Minnesota.

#SimilarOrganizations #People #Website #More

LUMINARY THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Life Science

Founded:
2019-01-01

Address:
Minneapolis, Minnesota, United States

Country:
United States

Website Url:
http://www.luminarytx.com

Total Employee:
1+

Status:
Active

Contact:
+1 612-309-7653

Email Addresses:
[email protected]

Total Funding:
2.32 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins


Similar Organizations

autobahn-therapeutics-logo

Autobahn Therapeutics

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

flare-therapeutics-logo

Flare Therapeutics

Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Current Employees Featured

john-hurley_image

John Hurley
John Hurley VP Finance & Business Development @ Luminary Therapeutics
VP Finance & Business Development
2020-02-01

david-largaespada_image

David Largaespada
David Largaespada Chairman & Co-Founder @ Luminary Therapeutics
Chairman & Co-Founder

branden-s-moriarity_image

Branden S. Moriarity
Branden S. Moriarity Chief Innovation Officer & Co-Founder @ Luminary Therapeutics
Chief Innovation Officer & Co-Founder

beau-webber_image

Beau Webber
Beau Webber Co-Founder and CSO @ Luminary Therapeutics
Co-Founder and CSO

jeff-s-liter_image

Jeff S. Liter
Jeff S. Liter CEO & Co-Founder @ Luminary Therapeutics
CEO & Co-Founder

Founder


beau-webber_image

Beau Webber

branden-s-moriarity_image

Branden S. Moriarity

david-largaespada_image

David Largaespada

jeff-s-liter_image

Jeff S. Liter

Official Site Inspections

http://www.luminarytx.com

  • Host name: 147.108.198.104.bc.googleusercontent.com
  • IP address: 104.198.108.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Luminary Therapeutics"

Home - Luminary Therapeutics

At Luminary, we are keenly focused on addressing the many challenges facing CAR T therapies. We developed a unique allogenic platform unlike any other. We are utilizing that platform to โ€ฆSee details»

About Us - Luminary Therapeutics

Luminary Therapeutics has purposefully created a combination of leading-edge science, business acumen and manufacturing power. Weโ€™ve built a multi-disciplinary team of leaders who team up and keep learning. Thatโ€™s good โ€ฆSee details»

Luminary Therapeutics - Crunchbase Company Profile โ€ฆ

View contacts for Luminary Therapeutics to access new leads and connect with decision-makers. Luminary Therapeutic is a cancer research center that โ€ฆSee details»

Luminary Therapeutics, Inc | LinkedIn

Luminary is a clinical stage CAR-T therapy company with a novel allogeneic manufacturing platform where our CAR and or TCR development utilizes gamma delta cells.See details»

Contact - Luminary Therapeutics

Contact. Jeff Liter President & CEO 612-309-7653 [email protected]. Address. 1200 Washington Avenue South Suite 260 Minneapolis, MN 55415 " *" indicates required fieldsSee details»

Luminary Therapeutics, Inc. Corp - VentureRadar

Website: https://www.luminarytx.com/ Develops innovative CAR-T therapies to address key challenges in cancer treatment, including antigen escape, T cell exhaustion, and allogeneic โ€ฆSee details»

Up & Running with Jeff Liter, President & CEO, โ€ฆ

Feb 14, 2021ย ยท Luminary is bringing to market cellular therapies aimed at overcoming antigen escape and is primarily focused on solid tumors as well as key autoimmune diseases. As a leader, how has your role changed during โ€ฆSee details»

Company Information - RocketReach

We have multiple solid tumor targets under development with a proprietary signaling method to ensure T-Cell persistence. Additionally, our Ligand BAFF CAR for hematologic cancers is โ€ฆSee details»

Luminary Therapeutics, Inc - Apollo.io

View Luminary Therapeutics, Inc (http://www.luminarytx.com) location in Minnesota, United States, revenue, competitors and contact information. Find and reach Luminary Therapeutics, โ€ฆSee details»

Luminary Therapeutics - Overview, News & Similar companies

Feb 23, 2021ย ยท View Luminary Therapeutics (www.luminarytx.com) location in Minnesota, United States , revenue, industry and description. Find related and similar companies as well as โ€ฆSee details»

Jeff Liter, MBA - Luminary Therapeutics

Jeff is a seasoned CEO with a proven track record at profitably growing emerging companies and business divisions. He has raised over $15M in seed capital from angel investors to start four โ€ฆSee details»

for development of BAFF CAR Reserve University enter formal ...

Cell therapy development company focused on non-viral autologous treatments for cancer and autoimmune diseases. Located in Minneapolis, Luminary. s team is comprised of academic, โ€ฆSee details»

Luminary therapeutics, inc Reviews | Read Client Reviews of โ€ฆ

Luminary therapeutics, inc Review Reviews 11. 4See details»

Luminary Therapeutics - BIO CEO & Investor Conference | BIO

Feb 6, 2023ย ยท The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»

Press Releases - Bio-Techne Corporation

MINNEAPOLIS, Feb. 23, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of a license agreement with Luminary Therapeutics for the use of โ€ฆSee details»

Luminary Spotlight - Luminary Therapeutics

Dec 21, 2022ย ยท The Myeloma Investment Fund (MIF), which is a venture philanthropy subsidiary of the Multiple Myeloma Research Foundation (MMRF), announced today that they are โ€ฆSee details»

Jeff Liter on LinkedIn: Proud of the Luminary team in announcing ...

???? ????????? ?? ???????????? ????????? ? 30 companies below categorised by 12 diseases and other/undiscovered autoimmune targets. ๏ธ Following on from my post...See details»

Luminary Therapeutics, Inc Email Format | luminarytx.com Emails

The most common Luminary Therapeutics, Inc email format is [first] (ex. [email protected]), which is being used by 46.9% of Luminary Therapeutics, Inc work email addresses.See details»

Luminary Therapeutics and Case Western Reserve University Enter โ€ฆ

Jul 7, 2020ย ยท Located in Minneapolis, Luminaryโ€™s team is comprised of academic, industry, and business leaders from top biotech and consulting organizations. Luminary seeks licensing โ€ฆSee details»

Luminate โ€“ Luminate

We work globally, with a regional focus in Africa, Asia, and Latin America. Luminate Strategic Initiatives works to address digital threats to democracy and is primarily focused on Europe. โ€ฆSee details»

linkstock.net © 2022. All rights reserved